Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study

Xu, Yinsong; Li, Yuanzhi

doi:10.1016/j.waojou.2024.100899

World Allergy Organization Journal

2024

DOI: 10.1016/j.waojou.2024.100899

|View full text |Cite

Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study

Yinsong Xu,

Yuanzhi Li

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 63 publications

(60 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Cazzola,

Page,

Hanania

et al. 2024

Drugs

View full text Add to dashboard Cite

Asthma and cardiovascular disease (CVD) often co-exist. When a patient has both conditions, management requires an approach that addresses the unique challenges of each condition separately, while also considering their potential interactions. However, specific guidance on the management of asthma in patients with CVD and on the management of CVD in patients with asthma is still lacking. Nevertheless, health care providers need to adopt a comprehensive approach that includes both respiratory and CVD health. The management of CVD in patients with asthma requires a delicate balance between controlling respiratory symptoms and minimising potential cardiovascular (CV) risks. In the absence of specific guidelines for the management of patients with both conditions, the most prudent approach would be to follow established guidelines for each condition independently. Careful selection of asthma medications is essential to avoid exacerbation of CV symptoms. In addition, optimal management of CV risk factors is essential. However, close monitoring of these patients is important as there is evidence that some asthma medications may have adverse effects on CVD and, conversely, that some CVD medications may worsen asthma symptoms. On the other hand, there is also increasing evidence of the potential beneficial effects of asthma medications on CVD and, conversely, that some CVD medications may reduce the severity of asthma symptoms. We aim to elucidate the potential risks and benefits associated with the use of asthma medications in patients with CVD, and the potential pulmonary risks and benefits for patients with asthma who are prescribed CVD medications.

show abstract

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Cazzola,

Page,

Hanania

et al. 2024

Drugs

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study

Cited by 1 publication

References 63 publications

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Contact Info

Product

Resources

About